apollomicsinc.com - APLM Operating profit EBITDA
Apollomics, Inc. (APLM) is optimizing expenses by outsourcing molecule development to external CRO contractors. Operating accruals before depreciation on GURU.Markets illustrate current trends, where 0.00 reflects the metric's baseline. The company is scaling anti-tumor therapies in the US and China, which mitigates regulatory risks. Additionally, the business is focusing on therapies for resistant forms of cancer through partnerships with leading clinics.
Summary analytical data breakdowns for Apollomics (APLM)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
APLM - Company Net Income|Expected Net Profit Apollomics, Inc.|APLM - Price to Earnings Ratio|Projected Price to Earnings Apollomics Inc.|APLM - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Apollomics|APLM - Operating profit EBITDA|Net earnings per share for the last 12 months Apollomics|APLM - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months apollomicsinc.com|APLM - Net earnings per share growth this year|Expected earnings per share trend next year Apollomics, Inc.
Analysis of all company metrics:Apollomics, Inc.
Fundamental asset screening requires a precise analysis of cash flow from operating activities before deducting financial expenses and depreciation. By analyzing the EBITDA metric, an investor assesses the real ability of Apollomics, Inc. (APLM) to act as a cash generator, which is critical for covering the development costs of oncology drugs in the US and China amid the high binary risks of the clinical pipeline.
Competitors of Apollomics, Inc. (APLM)
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|Operating profit EBITDA erasca.com (ERAS)|Profit before payment of interest, taxes and amortization Delcath Systems DCTH|YMAB (Y-mAbs Therapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|AURA - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Candel Therapeutics|Accuray Incorporated (ARAY) - Profit before payment of interest, taxes and amortization|SLS (SELLAS Life Sciences Group) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Actuate Therapeutics|Profit before payment of interest, taxes and amortization CTOR|Profit before payment of interest, taxes and amortization TuHURA Biosciences, Inc. (HURA)|TARA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Fate Therapeutics, Inc. FATE|WHWK - Operating profit before deduction of amortization|TScan - Operating profit EBITDA|Operating income before deduction of amortization Champions Oncology CSBR|XBIT: Operating profit EBITDA|Operating profit before deduction of amortization CEL-SCI|Profit before payment of interest, taxes and amortization OS Therapies Incorporated|radiopharmtheranostics.com (RADX) - Operating income before deduction of amortization|Operating profit before deduction of amortization ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA VERU (Veru Pharma)|Operating income before deduction of amortization Tempest Therapeutics Corp (TPST)|XLO - Profit before payment of interest, taxes and amortization|RENB (Renovaro Inc.) - Operating profit before amortization|MURA: Operating profit EBITDA|Operating profit before deduction of amortization Kairos Pharma|Operating profit before deduction of amortization OKUR|CytoMed (GDTC) - Operating income before deduction of amortization|Operating profit EBITDA CRIS|Operating profit EBITDA tharimmune.com (THAR)|Profit before payment of interest, taxes and amortization Advanced Biomed ADVB|GNPX (Genprex Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|CLDI - Profit before payment of interest, taxes and amortization|SBFM: Profit before payment of interest, taxes and amortization|xeneticbio.com (XBIO) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization salariuspharma.com|PPBT (Purple Biotech Ltd.) - Operating profit EBITDA|Operating profit before deduction of amortization AON (AONC)|Operating profit EBITDA BGNE|Operating profit EBITDA Checkpoint Therapeutics Inc (CKPT)|Profit before payment of interest, taxes and amortization Elevation Oncology ELEV|ICAD: Operating profit before amortization|Ikena - Operating profit EBITDA|Notable Labs Ltd (NTBL) - Operating profit before deduction of amortization|VIRX: Operating profit EBITDA|Profit before interest, taxes and amortization MorphoSys Corporation (MOR)|Profit before payment of interest, taxes and amortization NAYA Biosciences|AAPGV: Income before deduction of interest, taxes and amortization
